{"id":"W4391096243","doi":"10.1200/jco.2024.42.3_suppl.143","title":"BOLD-100-001 (TRIO039): A phase 2 study of BOLD-100 in combination with FOLFOX in patients with advanced mCRC previously treated with FOLFOX/CAPOX—Efficacy and safety analysis.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Translational Research in Oncology; McGill University; Jewish General Hospital; Ottawa Hospital; Princess Margaret Cancer Centre; Hamilton Health Sciences; University Health Network; Health Sciences Centre","funders":"","keywords":"FOLFOX; Medicine; Colorectal cancer; Internal medicine; Phases of clinical research; Progressive disease; Surgery; Oncology; Gastroenterology; Oxaliplatin; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001791776,0.001370738,0.001520749,0.0006245804,0.0003675908,0.0009435338,0.001072888,0.001139228,0.003387886],"category_scores_gemma":[0.0006411609,0.0006421675,0.00137339,0.0005540386,0.0009131695,0.0007298413,0.0004622549,0.003348219,0.0007697432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009175735,"about_ca_system_score_gemma":0.001642447,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001280078,"about_ca_topic_score_gemma":0.003510681,"domain_scores_codex":[0.9996057,0.0001955511,0.00002217522,0.00004992461,0.00004249648,0.0000841123],"domain_scores_gemma":[0.9992905,0.0001152115,0.0001310948,0.00005729856,0.00003700383,0.0003688629],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5641241,0.2145024,0.01278321,0.001059377,0.001860564,0.0006445206,0.0004503269,0.003672478,0.07978263,0.0003818497,0.004459801,0.1162787],"study_design_scores_gemma":[0.3257553,0.6537635,0.01067276,0.00003474513,0.0003949118,0.0003924358,0.00005489914,0.001475247,0.00543534,0.00009311313,0.001893454,0.00003423338],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941602,0.001370057,0.0004519016,0.0003016861,0.0000566973,0.001578989,0.0006236528,0.0000752646,0.001381712],"genre_scores_gemma":[0.9888643,0.001699998,0.001832553,0.0007026164,0.0001421999,0.001658335,0.002738138,0.00003315725,0.002328616],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003387886,"threshold_uncertainty_score":0.01133364,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04292805712188189,"score_gpt":0.4315394046302656,"score_spread":0.3886113475083837,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}